You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
3 September 2026 - EpiVax Inc, a provider of immunogenicity assessment and sequence optimisation for biologic therapeutics and vaccines, announced on Wednesday the release of AI-enabled enhancements to ISPRI, its proprietary in silico platform for as...
3 September 2026 - Foventa Therapeutics, a biotechnology company focused on novel therapies for retinal vascular diseases, announced on Wednesday that it has further strengthened its management team with the appointments of Dr Zaiba Malik as chief me...
Akeso's ivonescimab meets overall survival endpoint in interim analysis of Phase III HARMONi-2 study
3 September 2026 - Biopharmaceutical company Akeso Inc (HKEX:9926) announced on Wednesday that a pre-specified interim analysis in the HARMONi-2 (AK112-303) trial, as assessed by the Independent Data Monitoring Committee, met the key secondary endpoi...
2 September 2026 - Israel-based pharmaceutical company Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) on Wednesday reported positive top-line results from an ongoing Phase 2a study of TEV '408, an investigational anti-interleukin-15 m...
1 September 2026 - Biopharmaceutical company AstraZeneca PLC (STO: AZN; LON: AZN; NYSE: AZN) said on Tuesday it has completed its exclusive global licence agreement with China-based Dizal Pharmaceutical Co., Ltd (SSE: 688192) for Zegfrovy (sunvozerti...
1 September 2026 - British-Swedish biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) and Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) on Tuesday announced European Commission approval for Enhertu (trastuzumab de...
31 August 2026 - US pharmaceutical company Eli Lilly and Company (NYSE: LLY) on Monday announced that it has agreed to acquire Merida Biosciences, Inc., a biotechnology business developing precision biologics for autoimmune and allergic diseases.The ...